301509 金凯生科
交易中 11-27 13:35:21
资讯
新帖
简况
金凯生科最新公告：股东计划合计减持不超过9%公司股份
证券之星 · 11-26 18:51
金凯生科最新公告：股东计划合计减持不超过9%公司股份
金凯生科(301509.SZ)部分股东拟合计减持不超9%股份
智通财经 · 11-26 18:51
金凯生科(301509.SZ)部分股东拟合计减持不超9%股份
金凯生科：股东计划合计减持不超过9%公司股份
美港电讯 · 11-26 18:50
金凯生科：股东计划合计减持不超过9%公司股份
金凯生科(301509)11月20日股东户数1.17万户，较上期减少0.19%
证券之星 · 11-21
金凯生科(301509)11月20日股东户数1.17万户，较上期减少0.19%
金凯生科(301509)11月8日股东户数1.17万户，较上期增加1.85%
证券之星 · 11-11
金凯生科(301509)11月8日股东户数1.17万户，较上期增加1.85%
金凯生科(301509)10月31日股东户数1.15万户，较上期减少2.19%
证券之星 · 11-05
金凯生科(301509)10月31日股东户数1.15万户，较上期减少2.19%
金凯生科（301509）10月30日主力资金净卖出680.46万元
证券之星 · 10-31
金凯生科（301509）10月30日主力资金净卖出680.46万元
金凯生科：董秘回答投资者关注信息披露事项
问董秘 · 10-30
金凯生科：董秘回答投资者关注信息披露事项
金凯生科业绩上市即变脸：三季度扣非净利润不足50万元 理财收益成为主要利润来源
新浪证券 · 10-25
金凯生科业绩上市即变脸：三季度扣非净利润不足50万元 理财收益成为主要利润来源
金凯生科（301509）2024年三季报简析：净利润减73.13%
证券之星 · 10-25
金凯生科（301509）2024年三季报简析：净利润减73.13%
图解金凯生科三季报：第三季度单季净利润同比减79.02%
证券之星 · 10-23
图解金凯生科三季报：第三季度单季净利润同比减79.02%
金凯生科(301509.SZ)发布前三季度业绩，净利润3929.06万元，同比下降73.13%
智通财经 · 10-23
金凯生科(301509.SZ)发布前三季度业绩，净利润3929.06万元，同比下降73.13%
金凯生科(301509)10月18日股东户数1.17万户，较上期减少0.16%
证券之星 · 10-21
金凯生科(301509)10月18日股东户数1.17万户，较上期减少0.16%
A股减肥药板块局部异动，常山药业直线拉升逼近20CM涨停，博瑞医药、翰宇药业、金凯生科、百花医药等跟涨。
美港电讯 · 10-17
A股减肥药板块局部异动，常山药业直线拉升逼近20CM涨停，博瑞医药、翰宇药业、金凯生科、百花医药等跟涨。
金凯生科(301509)10月10日股东户数1.18万户，较上期减少8.32%
证券之星 · 10-14
金凯生科(301509)10月10日股东户数1.18万户，较上期减少8.32%
金凯生科（301509）9月26日主力资金净买入53.25万元
证券之星 · 09-27
金凯生科（301509）9月26日主力资金净买入53.25万元
金凯生科（301509）9月24日主力资金净买入49.89万元
证券之星 · 09-25
金凯生科（301509）9月24日主力资金净买入49.89万元
金凯生科(301509)9月20日股东户数1.28万户，较上期减少2.19%
证券之星 · 09-23
金凯生科(301509)9月20日股东户数1.28万户，较上期减少2.19%
金凯生科：公司募集资金及理财情况请您关注公司定期报告及相关募集资金情况的公告
证券之星 · 09-12
金凯生科：公司募集资金及理财情况请您关注公司定期报告及相关募集资金情况的公告
金凯生科：创新药外包专业化分工是大势所趋
证券日报 · 09-11
金凯生科：创新药外包专业化分工是大势所趋
加载更多
公司概况
公司名称：
金凯(辽宁)生命科技股份有限公司
所属行业：
医药制造业
上市日期：
2023-08-03
主营业务：
金凯(辽宁)生命科技股份有限公司的主营业务为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。公司主要产品包括含氟类产品、非含氟类产品等。公司曾获得专精特新“小巨人”企业、高新技术企业、省级企业技术中心等。
发行价格：
56.56
{"stockData":{"symbol":"301509","market":"SZ","secType":"STK","nameCN":"金凯生科","latestPrice":28.2,"timestamp":1732685721000,"preClose":30.08,"halted":0,"volume":3172721,"delay":0,"floatShares":56740900,"shares":120000000,"eps":0.5535,"marketStatus":"交易中","marketStatusCode":2,"change":-1.88,"latestTime":"11-27 13:35:21","open":28.69,"high":28.96,"low":27.74,"amount":89485200,"amplitude":0.0406,"askPrice":28.24,"askSize":19,"bidPrice":28.2,"bidSize":24,"shortable":0,"etf":0,"ttmEps":0.5535,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732690800000},"adr":0,"adjPreClose":30.08,"symbolType":"stock","openAndCloseTimeList":[[1732671000000,1732678200000],[1732683600000,1732690800000]],"highLimit":33.09,"lowLimit":27.07,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120446669,"pbRate":1.69,"roa":"--","roe":"1.82%","epsLYR":2.42,"committee":0.083333,"marketValue":3397000000,"floatMarketCap":1600000000,"peRate":50.94851,"changeRate":-0.0625,"turnoverRate":0.0559,"status":1},"requestUrl":"/m/hq/s/301509","defaultTab":"news","newsList":[{"id":"2486020728","title":"金凯生科最新公告：股东计划合计减持不超过9%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486020728","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486020728?lang=zh_cn&edition=full","pubTime":"2024-11-26 18:51","pubTimestamp":1732618279,"startTime":"0","endTime":"0","summary":"金凯生科公告，公司股东启鹭投资计划通过集中竞价和大宗交易方式减持公司股份不超过361.20万股，占公司总股本比例3%。蓝区基金计划通过集中竞价和大宗交易方式减持公司股份不超过361.20万股，占公司总股本比例3%。青松投资计划通过集中竞价和大宗交易方式减持公司股份不超过361.20万股，占公司总股本比例3%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600032202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2486788210","title":"金凯生科(301509.SZ)部分股东拟合计减持不超9%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486788210","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486788210?lang=zh_cn&edition=full","pubTime":"2024-11-26 18:51","pubTimestamp":1732618277,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金凯生科(301509.SZ)公告，公司股东启鹭(厦门)股权投资合伙企业(有限合伙)(简称“启鹭投资”)、股东蓝色经济区产业投资基金(有限合伙)(简称“蓝区基金”)、股东青岛青松创业投资集团有限公司-青岛松凯创业投资企业(有限合伙)(简称“青松投资”)计划合计减持公司股份不超过1083.6万股，占公司总股本比例9%，","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2486020148","title":"金凯生科：股东计划合计减持不超过9%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486020148","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486020148?lang=zh_cn&edition=full","pubTime":"2024-11-26 18:50","pubTimestamp":1732618247,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2485745455","title":"金凯生科(301509)11月20日股东户数1.17万户，较上期减少0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485745455","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485745455?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:04","pubTimestamp":1732179846,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2024年11月20日公司股东户数为1.17万户，较11月8日减少22.0户，减幅为0.19%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至11月20日，医疗服务行业平均股东户数为4.51万户。从股价来看，2024年11月8日至2024年11月20日，金凯生科区间涨幅为1.26%，在此期间股东户数减少22.0户，减幅为0.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100026894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2482270812","title":"金凯生科(301509)11月8日股东户数1.17万户，较上期增加1.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482270812","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482270812?lang=zh_cn&edition=full","pubTime":"2024-11-11 17:04","pubTimestamp":1731315871,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2024年11月8日公司股东户数为1.17万户，较10月31日增加213.0户，增幅为1.85%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至11月8日，医疗服务行业平均股东户数为4.51万户。从股价来看，2024年10月31日至2024年11月8日，金凯生科区间涨幅为2.63%，在此期间股东户数增加213.0户，增幅为1.85%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100021974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2481521436","title":"金凯生科(301509)10月31日股东户数1.15万户，较上期减少2.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481521436","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481521436?lang=zh_cn&edition=full","pubTime":"2024-11-05 17:03","pubTimestamp":1730797436,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2024年10月31日公司股东户数为1.15万户，较10月18日减少257.0户，减幅为2.19%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至10月31日，医疗服务行业平均股东户数为4.51万户。从股价来看，2024年10月18日至2024年10月31日，金凯生科区间跌幅为5.28%，在此期间股东户数减少257.0户，减幅为2.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500028546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2479718797","title":"金凯生科（301509）10月30日主力资金净卖出680.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479718797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479718797?lang=zh_cn&edition=full","pubTime":"2024-10-31 09:24","pubTimestamp":1730337857,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月30日收盘，金凯生科报收于30.87元，下跌2.89%，换手率4.18%，成交量2.37万手，成交额7362.62万元。近5日资金流向一览见下表：金凯生科融资融券信息显示，融资方面，当日融资买入543.26万元，融资偿还763.53万元，融资净偿还220.27万元。金凯生科主营业务：为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100012925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2479122593","title":"金凯生科：董秘回答投资者关注信息披露事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2479122593","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479122593?lang=zh_cn&edition=full","pubTime":"2024-10-30 15:48","pubTimestamp":1730274480,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n投资者提问：公司上市后业绩连续大幅度下滑，控股股东有无资产重组的计划？董秘回答(金凯生科SZ301509)：尊敬的投资者，您好！截至目前，公司无应披露未披露的信息。公司后续如有涉及资产重组等重大事项，将严格按照相关规定及时履行信息披露义务。感谢您对公司的关注！查看更多董秘问答>>免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确性，内容仅供参考。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-10-30/doc-incuipeu1030602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2478609622","title":"金凯生科业绩上市即变脸：三季度扣非净利润不足50万元 理财收益成为主要利润来源","url":"https://stock-news.laohu8.com/highlight/detail?id=2478609622","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478609622?lang=zh_cn&edition=full","pubTime":"2024-10-25 17:50","pubTimestamp":1729849800,"startTime":"0","endTime":"0","summary":" 近日，金凯生科发布2024年第三季度报告，公司业绩大幅下滑，营业收入同比下降33.93%，扣非净利润同比下滑超8成。2023年，公司登陆创业板，在此之前各报告期内公司业绩增长强劲，2023年公司营收、利润增速均显著优于行业平均水平。 而上市次年，公司业绩变脸，单季度扣非净利润不足50万元，理财收益成为主要的利润来源。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2024-10-25/doc-inctuivt5559928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301509"],"gpt_icon":0},{"id":"2478973156","title":"金凯生科（301509）2024年三季报简析：净利润减73.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478973156","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478973156?lang=zh_cn&edition=full","pubTime":"2024-10-25 06:10","pubTimestamp":1729807844,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金凯生科发布2024年三季报。根据财报显示，金凯生科净利润减73.13%。截至本报告期末，公司营业总收入3.87亿元，同比下降33.93%，归母净利润3929.06万元，同比下降73.13%。按单季度数据看，第三季度营业总收入1.25亿元，同比下降18.72%，第三季度归母净利润719.88万元，同比下降79.02%。公司 2024 年半年度经营活动现金流量净额为 6,527.28 万元，同比增长 114.94%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500005429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509"],"gpt_icon":0},{"id":"2477370136","title":"图解金凯生科三季报：第三季度单季净利润同比减79.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477370136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477370136?lang=zh_cn&edition=full","pubTime":"2024-10-23 16:47","pubTimestamp":1729673223,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科2024年三季报显示，公司主营收入3.87亿元，同比下降33.93%；归母净利润3929.06万元，同比下降73.13%；扣非净利润2495.81万元，同比下降82.84%；其中2024年第三季度，公司单季度主营收入1.25亿元，同比下降18.72%；单季度归母净利润719.88万元，同比下降79.02%；单季度扣非净利润45.57万元，同比下降98.66%；负债率6.33%，投资收益1310.89万元，财务费用-329.95万元，毛利率39.11%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300027173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509"],"gpt_icon":0},{"id":"2477537425","title":"金凯生科(301509.SZ)发布前三季度业绩，净利润3929.06万元，同比下降73.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477537425","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477537425?lang=zh_cn&edition=full","pubTime":"2024-10-23 16:17","pubTimestamp":1729671463,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金凯生科(301509.SZ)发布2024年三季度报告，前三季度，公司实现营业收入3.87亿元，同比下降33.93%。归属于上市公司股东的净利润3929.06万元，同比下降73.13%。归属于上市公司股东的扣除非经常性损益的净利润2495.81万元，同比下降82.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197968.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301509"],"gpt_icon":0},{"id":"2477836074","title":"金凯生科(301509)10月18日股东户数1.17万户，较上期减少0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477836074","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477836074?lang=zh_cn&edition=full","pubTime":"2024-10-21 17:05","pubTimestamp":1729501556,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2024年10月18日公司股东户数为1.17万户，较10月10日减少19.0户，减幅为0.16%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至10月18日，医疗服务行业平均股东户数为4.44万户。从股价来看，2024年10月10日至2024年10月18日，金凯生科区间涨幅为3.33%，在此期间股东户数减少19.0户，减幅为0.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102100021827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2476350211","title":"A股减肥药板块局部异动，常山药业直线拉升逼近20CM涨停，博瑞医药、翰宇药业、金凯生科、百花医药等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2476350211","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476350211?lang=zh_cn&edition=full","pubTime":"2024-10-17 10:22","pubTimestamp":1729131779,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0188","BK0070","399300","688166","BK0028","BK0172","300255","159982","BK0239","BK0216","BK0077","BK0102","301509","300199","600721"],"gpt_icon":0},{"id":"2475208358","title":"金凯生科(301509)10月10日股东户数1.18万户，较上期减少8.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475208358","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475208358?lang=zh_cn&edition=full","pubTime":"2024-10-14 17:05","pubTimestamp":1728896755,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2024年10月10日公司股东户数为1.18万户，较9月30日减少1067.0户，减幅为8.32%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至10月10日，医疗服务行业平均股东户数为4.45万户。从股价来看，2024年9月30日至2024年10月10日，金凯生科区间跌幅为6.39%，在此期间股东户数减少1067.0户，减幅为8.32%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101400022767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2470719246","title":"金凯生科（301509）9月26日主力资金净买入53.25万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470719246","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470719246?lang=zh_cn&edition=full","pubTime":"2024-09-27 09:19","pubTimestamp":1727399968,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月26日收盘，金凯生科报收于27.88元，上涨0.18%，换手率7.1%，成交量4.03万手，成交额1.11亿元。近5日资金流向一览见下表：金凯生科融资融券信息显示，融资方面，当日融资买入986.77万元，融资偿还943.56万元，融资净买入43.22万元，连续3日净买入累计251.96万元。金凯生科主营业务：为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092700006553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2470475182","title":"金凯生科（301509）9月24日主力资金净买入49.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470475182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470475182?lang=zh_cn&edition=full","pubTime":"2024-09-25 09:26","pubTimestamp":1727227595,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月24日收盘，金凯生科报收于26.84元，上涨1.21%，换手率7.84%，成交量4.45万手，成交额1.17亿元。近5日资金流向一览见下表：金凯生科融资融券信息显示，融资方面，当日融资买入850.82万元，融资偿还721.33万元，融资净买入129.49万元。金凯生科主营业务：为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092500007738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2469160272","title":"金凯生科(301509)9月20日股东户数1.28万户，较上期减少2.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469160272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469160272?lang=zh_cn&edition=full","pubTime":"2024-09-23 17:06","pubTimestamp":1727082379,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2024年9月20日公司股东户数为1.28万户，较9月10日减少286.0户，减幅为2.19%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至9月20日，医疗服务行业平均股东户数为4.45万户。从股价来看，2024年9月10日至2024年9月20日，金凯生科区间跌幅为5.72%，在此期间股东户数减少286.0户，减幅为2.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092300020162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2466922461","title":"金凯生科：公司募集资金及理财情况请您关注公司定期报告及相关募集资金情况的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2466922461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466922461?lang=zh_cn&edition=full","pubTime":"2024-09-12 18:03","pubTimestamp":1726135405,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科09月12日在投资者关系平台上答复投资者关心的问题。公司募集资金及理财情况请您关注公司定期报告及相关募集资金情况的公告。公司重视投资者回报，也会认真听取投资者建议。公司将根据法律法规、国家政策并结合多种因素综合考虑论证，如公司后续有相关回购计划，将会严格按照规定进行信息披露。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200029944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2466445505","title":"金凯生科：创新药外包专业化分工是大势所趋","url":"https://stock-news.laohu8.com/highlight/detail?id=2466445505","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466445505?lang=zh_cn&edition=full","pubTime":"2024-09-11 01:04","pubTimestamp":1725987840,"startTime":"0","endTime":"0","summary":" 在金凯生科9月10日召开的2024年半年度业绩说明会上，公司董事会秘书、财务总监王琦在与投资者交流时表示，创新药外包专业化分工是大势所趋，CDMO行业在医药创新的大趋势下依然大有可为。2024年半年报显示，受行业景气度影响，金凯生科经营业绩出现下滑。 金凯生科董事长王富民在业绩说明会上表示，从中长期来看，全球医药市场将依然保持稳定增长，医药外包服务趋势不减，CDMO行业仍然大有可为。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-09-11/doc-incnsyne9025658.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-09-11/doc-incnsyne9025658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","06978","301509","BK1161","BK0239","BK1574"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2023-08-03","address":"辽宁省阜新市阜新蒙古族自治县伊吗图镇氟化工园区安仁路6号","stockEarnings":[{"period":"1week","weight":-0.0448},{"period":"1month","weight":-0.0926},{"period":"3month","weight":0.1764},{"period":"6month","weight":-0.1711},{"period":"1year","weight":-0.4049},{"period":"ytd","weight":-0.3237}],"companyName":"金凯(辽宁)生命科技股份有限公司","boardCode":"AI0027","perCapita":"4857股","boardName":"医药制造业","registeredCapital":"12044万元","compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0121},{"period":"3month","weight":0.1488},{"period":"6month","weight":0.0544},{"period":"1year","weight":0.0752},{"period":"ytd","weight":0.0957}],"survey":" 金凯(辽宁)生命科技股份有限公司的主营业务为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。公司主要产品包括含氟类产品、非含氟类产品等。公司曾获得专精特新“小巨人”企业、高新技术企业、省级企业技术中心等。","serverTime":1732685724919,"listedPrice":56.56,"stockholders":"11680人(较上一季度减少0.19%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金凯生科,301509,金凯生科股票,金凯生科股票老虎,金凯生科股票老虎国际,金凯生科行情,金凯生科股票行情,金凯生科股价,金凯生科股市,金凯生科股票价格,金凯生科股票交易,金凯生科股票购买,金凯生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}